Received Jun 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | IM / RA |
burning sensation underneath her left shoulder blade in her back; This non-serious case was reported by a consumer via call center representative and described the occurrence of burning sensation in a 70-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Concurrent medical conditions included tick bite, diabetes, blood pressure high, blood cholesterol increased, indigestion and heartburn. Concomitant products included doxycycline, semaglutide (Ozempic) and potassium. On 28-MAY-2025, the patient received the 1st dose of Shingrix (intramuscular, right arm). On 29-MAY-2025, 1 days after receiving Shingrix, the patient experienced burning sensation (Verbatim: burning sensation underneath her left shoulder blade in her back). The outcome of the burning sensation was not resolved. It was unknown if the reporter considered the burning sensation to be related to Shingrix. It was unknown if the company considered the burning sensation to be related to Shingrix. Additional Information: GSK Receipt Date: 02-JUN-2025 The patient received first dose of Shingrix in her right arm on 28-MAY-2025, and reported that the next night 29-MAY-2025, she started having a deep, burning sensation underneath her left shoulder blade in her back. The patient reported that this sensation was still there today on 2-JUN-2025, but was not as bad as it was. The patient also reported that she was taking Doxycycline 100MG (Unknown Product Information) by mouth twice a day for a tick bite that was diagnosed on 13-APR-2025, and she started this antibiotic the evening of 29-MAY-2025, after receiving the first dose of Shingrix.
Blood cholesterol increased; Blood pressure high; Diabetes; Heartburn; Indigestion; Tick bite
DOXYCYCLINE; OZEMPIC; POTASSIUM